External Control Arms (ECA) address some of the practical, ethical and cost challenges of recruiting in-trial randomized control arms. Yet ECAs have their own limitations. Mechanistic modeling, such as the modeling developed at Novadiscovery , can create more robust ECAs that overcome these limitations and provide deeper insights into treatment effects at both the population and individual patient level.
Limitations of RWD current approach
Nova’s Synthetic Control Arms
Beyond SCAs : intra-patients controls
Download white paper
Get your questions answered by downloading the free pdf and learn more about our study!